|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 1/00 | |
| C07H 19/10 | |||
| C07F 9/22 | |||
| C07F 9/6558 | |||
| C07F 9/24 | |||
| A61K 31/7072 | |||
| A61K 31/716 | |||
| A61P 31/14 |
| (11) | Number of the document | 2913337 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15152203.4 |
| Date of filing the European patent application | 2010-05-20 | |
| (97) | Date of publication of the European application | 2015-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 179923 P | 2009-05-20 | US | |
| 319513 P | 2010-03-31 | US |
| (72) |
Ross, Bruce S., US
Sofia, Michael Joseph, US
Pamulapati, Ganapati Reddy, US
Rachakonda, Suguna, US
Zhang, Hai-Ren, US
Chun, Byoung-Kwon, US
Wang, Peiyuan, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | PROCESS FOR THE PRODUCTION OF SOFOSBUVIR |
| PROCESS FOR THE PRODUCTION OF SOFOSBUVIR |